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pletely. The 5-HT2A receptor belongs to the serotonin receptor
family, namely the inhibition of variant angina attack could be
mediated via blockage of serotonin-induced signals. Although
sarpogrelate hydrochloride was administered in addition to other
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>Variant angina pectoris is well known to be caused by reversible
asospasm on coronary artery. Indeed, although many variant
ngina patients have been diagnosed and treated worldwide, its
recise mechanism remains to be elucidated. On the other hand,
therosclerosis-mediated structural stenosis on coronary artery
ould evoke angina attack on effort in patients with atheroscle-
otic angina. Therefore, it may  be quite plausible that there are
ifferent mechanisms in the pathogenesis between effort angina
nd variant angina. So far, endothelial function has been reported
o be impaired in patients with cardiovascular risk factors such as
ypertension, dyslipidemia, diabetes mellitus, and smoking habit,
eading to the onset and progression of atherosclerosis, which could
ubsequently result in cardiovascular events including coronary
rtery disease and cerebral stroke. In other words, endothelial dys-
unction, viz. less release of nitric oxide from endothelium, could
e usually and frequently found in patients with coronary artery
isease. Similarly, endothelial dysfunction has been reported in
atients with variant angina as well [1].  Rho-associated kinase
ROCK) has been shown as one of the critical target molecules to
ause coronary vasospasm [2].  In vascular smooth muscle cells,
OCK mainly plays a critical role in vasoconstriction via mod-
lation of Ca2+ sensitivity. In endothelial cells, ROCK has been
lso revealed to correlate with endothelial dysfunction [3]. Fur-
hermore, ROCK activation has been reported to be clinically
nvolved in patients with not only variant angina, but also effort
ngina [2].  Accordingly, endothelial dysfunction and increased
OCK activity in vasculature could play critical roles in both effort
nd variant angina. Nevertheless, the accurate difference of the
echanisms between effort angina and variant angina remains
nclear.
Previously, the correlation between allergy and coronary
asospasm has been reported [4,5]. Sakata et al. have demonstrated
 possible relationship of histamine with coronary vasospasm, i.e.
he plasma concentration of histamine was elevated in patients
ith variant angina compared to that in control patients [6,7].
istamine, released from mast cells and circulating basophils, is
ell known as one of the pivotal mediators for allergic diseases
uch as bronchial asthma and urticaria [8].  Indeed, it has been
eported that mast cells in the adventitia of coronary artery are
ubstantially related to coronary vasospasm, but to a lesser extent
o coronary atherosclerosis [9].  Therefore, it appears to be quite
ossible that the release of histamine from mast cells located in
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ttp://dx.doi.org/10.1016/j.jccase.2012.10.001coronary adventitia could evoke, at least in part, vasospasm in
coronary arteries in patients with variant angina. Serotonin, similar
to histamine, is also known to relate to bronchial asthma, an allergic
disease. Indeed, Lechin et al. have shown that plasma serotonin lev-
els were elevated in patients with asthma and the serotonin levels
had a signiﬁcant correlation with asthma severity [10]. Also, pos-
sible usage of serotonin receptor antagonists for asthma patients
has been discussed [11]. However, the major source of serotonin
in humans is platelets, which is different from histamine [8].  To
date, a substantial relationship of variant angina with serotonin
has not been elucidated. Interestingly, although a possible path-
way of allergy-mediated vasospasm has been reported, it remains
unknown whether allergy-mediated increases of histamine and/or
serotonin could evoke endothelial dysfunction and/or increased
ROCK activity (Fig. 1).
In this issue of the journal, a case report study demonstrated that
the symptoms of refractory variant angina attack in the patient had
a seasonal trend which is consistent with the allergy season evoked
by Dermatophagoides farina [12]. Indeed, an allergic screening test
revealed the presence of the patient’s allergic reaction to D. farina.
Of great interest, the additional administration of sarpogrelate
hydrochloride, an antagonist of the 5-hydroxytryptamine subtype
2A (5-HT2A) receptor, improved the refractory angina attack com-Coronary Vasospasm
Fig. 1. A possible pathway of allergy-mediated coronary vasospasm. ROCK,
Rho-associated kinase.
vier Ltd. All rights reserved.
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gents such as nicorandil, diltiazem, benidipine, nifedipine, and
sosorbide dinitrate in the study, there might be other appropriate
ases in which sarpogrelate hydrochloride should be administered
ot only as an additional agent, but also as a ﬁrst- or second-choice
gent. Taken together, a critical hint to determine the cases
or the appropriate use of sarpogrelate hydrochloride has been
uggested by Liu et al. Hence, sarpogrelate hydrochloride could
e a novel and useful agent for the treatment of variant angina
atients with seasonal trend attacks. Further studies are needed
nd awaited with great respect in order to convince the possible
pplication of sarpogrelate hydrochloride to patients with variant
ngina.
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